Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
Symbol TEAD1 contributors: mct - updated : 06-03-2019
HGNC name TEA domain family member 1 (SV40 transcriptional enhancer factor)
HGNC id 11714
Corresponding disease
AA atrophia areata
AIC2 Aicardi syndrome 2
Location 11p15.3      Physical location : 12.695.968 - 12.966.283
Synonym name
  • SV40 transcriptional enhancer factor
  • transcriptional enhancer factor 1
  • protein GT-IIc
  • transcription factor 13
  • Synonym symbol(s) TEF1, TCF13, TEF-1, REF1, NTEF-1, TCF-13, TEAD-1, FLJ17970
    TYPE functioning gene
    STRUCTURE 270.33 kb     13 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked   status confirmed
    Map pter - AMPD3 - D11S1346 - D11S688 - CSNK2A1P /D11S1315 - TEAD1 - D11S634 - D11S926 - PTH PTH - D11S1348 - CALCA - cen
    Physical map
    CMT4B2 11p15.3 Charcot-Marie-Tooth neuropathy 4B2 (autosomal recessive, with myelin outfolding) ADM 11p15.4 adrenomedullin LOC338749 11p15.3 hypothetical LOC338749 AMPD3 11p15 adenosine monophosphate deaminase (isoform E) RNF141 11p15.3 ring finger protein 141 XLKD1 11p15 extracellular link domain containing 1 MRVI1 11p15 murine retrovirus integration site 1 homolog SH2BP1 11pter-p15.4 SH2 domain binding protein 1 (tetratricopeptide repeat containing) EIF4G2 11p15 eukaryotic translation initiation factor 4 gamma, 2 LOC58486 11p15.3 transposon-derived Buster1 transposase-like protein MGC71806 11p15.3 similar to Hypothetical protein LOC233733 USP47 11p15.2 ubiquitin specific protease 47 RIG 11p15.1 ubiquitin specific protease 47 DKK3 11p15.2 dickkopf homolog 3 (Xenopus laevis) MICAL2 11p15.2 dickkopf homolog 3 (Xenopus laevis) FLJ14966 11p15.3 hypothetical protein FLJ14966 PARVA 11p15.2 parvin, alpha TEAD1 11p15.2 TEA domain family member 1 (SV40 transcriptional enhancer factor) LOC119593 11p15.3 similar to RIKEN cDNA 4632411J06 ARNTL 11p15 aryl hydrocarbon receptor nuclear translocator-like GMRP-1 11p15.3-p15.2 K+ channel tetramerization protein PTH 11p15.2-p15.1 parathyroid hormone FLJ22728 11p15.2 hypothetical protein FLJ22728 LOC338750 11p15.2 similar to hypothetical protein FLJ33167 LOC387754 11 LOC387754 SPON1 11p15.2-p14 spondin 1, (f-spondin) extracellular matrix protein RRAS2 11p15.2 related RAS viral (r-ras) oncogene homolog 2 LOC390094 11 similar to ribosomal protein L13a; 60S ribosomal protein L13a; 23 kD highly basic protein COPB 11p15.4-p15.2 coatomer protein complex, subunit beta PSMA1 11p15.1 proteasome (prosome, macropain) subunit, alpha type, 1 PDE3B 11p15.1 phosphodiesterase 3B, cGMP-inhibited MORF4LP3 11p mortality factor 4 like pseudogene 3 CYP2R1 11p15.2 cytochrome P450, family 2, R1 CALCP 11p15.2-p15.1 calcitonin pseudogene CALCA 11p15.2-p15.1 calcitonin/calcitonin-related polypeptide, alpha OR7E41P 11p15 olfactory receptor, family 7, subfamily E, member 41 pseudogene CALCB 11p15.2-p15.1 calcitonin-related polypeptide, beta LOC387755 11 similar to RIKEN cDNA 3830422K02 LOC387756 11 LOC387756
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    13 splicing 9433 - 426 - 1991 1851669
    Type ubiquitous
       expressed in (based on citations)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
     parathyroid   highly
    Nervousbrain     Homo sapiens
    Reproductivefemale systemplacenta   
    Visualeyeretina    Homo sapiens
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal predominantly
    SystemCellPubmedSpeciesStageRna symbol
    VisualMuller cell Homo sapiens
    cell lineage
    cell lines
    at STAGE
  • an N-terminal DNA-binding TEA (TEF-1, TEC1, and AbaA) domain, conserved DNA-binding TEA domain, which binds to the MCAT cis-acting regulatory element
  • a C-terminal YAP-binding domain (YBD)
    interspecies homolog to murine Tead1 (99.3pc)
    homolog to rattus Tead1 (99.5pc)
  • TEA/ATTS domain family
  • CATEGORY regulatory , transcription factor
        plasma membrane
    basic FUNCTION
  • required for cardiac muscle specific genes expression
  • transduction of a variety of genes
  • playing essential roles in mediating biological functions of YAP1
  • transcriptional enhancer factor
  • directing the transactivation of several genes and in placental cells can act as a transcriptional repressor
  • inhibiting prolactin gene expression in uterine decidual cells, probably by interacting directly with other transcription factors
  • mediating activation of IFITM3 gene
  • mammalian Tead proteins regulate cell proliferation and contact inhibition as a transcriptional mediator of Hippo signaling
  • proapoptotic function for TEAD1 and a non physiological cytoprotective effect for overexpressed TEAD1
  • is an integral component of the transcription factor combinatorial code of pancreatic progenitor enhancers
  • central role for TEAD1 and YAP1 as signal-responsive regulators of multipotent pancreatic progenitors
  • TEAD1 was the major transcription factor of Hippo signaling pathway in osteosarcoma
  • TEAD1 promotes vascular smooth muscle cells (VSMCs) proliferation via transcriptional induction of SLC1A5, thereby activating MTOR signaling and promoting neointima formation
  • cell-autonomous TEAD1 function is required for normal cardiomyocyte proliferation
  • non-redundant critical requirement for TEAD1 in regulating cell cycle proteins and proliferation in cardiomyocytes in the perinatal heart
  • CELLULAR PROCESS nucleotide, transcription, regulation
    signaling signal transduction
  • component in the Hippo pathway
  • YAP1-TEAD1 signaling induces mitochondrial biogenesis in endothelial cells (ECs) and stimulates angiogenesis through PPARGC1A
  • a component
    DNA binding specifically and cooperatively to the SPH and GT-IIC "enhansons" and activating transcription in a cell specific manner
  • binding to a TEAD1-binding site in the prolactin promoter
  • RNA
    small molecule
  • interacting with the MADS domain of SRF to coactivate the skeletal alpha-actinin promoter and with MEF2 factors (control of MEF2-dependent muscle-specific gene expression)
  • interacting with VGLL4 (modulates the activity of TEAD1 factors and counteracts alpha1-adrenergic activation of gene expression in cardiac myocytes)
  • interact with YAP1 (which lacks a DNA-binding domain but contains an activation domain) to form functional heterodimeric transcription factors that activate proliferative and prosurvival gene expression programs
  • new, BIRC7-dependent, apoptotic role for TEAD1
  • TEAD1 may mediate muscle development through its target genes, MRPL21, NDUFA6 and CCNE1
  • regulation of NAIP by TEAD1/YAP1 is at the transcriptional level
  • TEAD1 is a novel general repressor of smooth muscle-specific gene expression through interfering with MYOCD binding to SRF
  • CIZ1 enhanced the interaction between YAP1 and TEAD1
  • TEAD1 is a novel regulator of PMP22 expression during development in concert with SOX10 and EGR2
  • NUP37 interacted with YAP1 and activated YAP1/TEAD1 signaling by enhancing the interaction between YAP1 and TEAD1
  • YAP1 binds to the TEA domain (TEAD1) transcription factor and controls angiogenesis
  • TEAD1 overexpression restores AQP4 expression, and both TEAD1 and AQP4 overexpression rescue migratory deficits in TEAD1-knockout cells, implicating a direct regulatory role for TEAD1-AQP4 in glioblastoma (GBM) migration
  • SLC1A5, a key glutamine transporter, is a novel TEAD1 target gene
  • cell & other
    corresponding disease(s) AA , AIC2
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in hepatocellular carcinoma (HCC), and overexpression is involved in the growth and differentiation of HCC
    suppressed multiple malignant phenotypes of osteosarcoma cells including cell proliferation, apoptosis resistance, and invasive potential
    Variant & Polymorphism
    Candidate gene
  • prostate basal cell marker that correlate with poor clinical outcome in prostate cancer
  • Marker
    Therapy target
  • transgenic mice overexpressing TEAD1 showed an age-dependent heart dysfunction
  • homozygous mutant mice embryos with a targeted disruption of the TEAD1 gene displayed abnormal heart development and died between embryonic days 11 and 12
  • murine Tead1-deficient cardiomyocytes have significantly decreased proliferation during the immediate postnatal period, when proliferation rate is normally high